Meeting on the Mesa 2026 has ended. This guide stays up as the record of who was there. Next: Meeting on the Mesa 2027, Oct 18–20, 2027 in Phoenix

Pharma and large biotech companies at Meeting on the Mesa 2026

Oct 5–7, 2026 Phoenix, AZ ~1.5k attendees Website

28 pharma and large biotech companies are at Meeting on the Mesa 2026 — 15 presentations on the program. Most represented: Astellas (1 on the program), Bristol Myers Squibb (2 on the program), Pierre Fabre Pharmaceuticals (1 on the program). 14 of them have their own page in this guide. As of Oct 6, 2026.

All 592 organizations at Meeting on the Mesa 2026 →

Focus area
Top represented
Showing 1–18 of 28 organizations
OrganizationMeeting on the Mesa 2026 Attendance
Astellas
Tokyo, Japan
◆Diamond Sponsor
Pharma & large biotechDiamond Sponsor
Develops and commercializes medicines, with partnering interests in oncology, rare diseases, immunology, cell therapies and gene therapies.
Spotlight
Tue, Oct 6
3:30pm
Innovation Spotlight company presentation
Panel
Tue, Oct 6
10:30am
Evotec
Hamburg, Germany
◇Bronze Sponsor
Pharma & large biotechBronze Sponsor
Develops therapeutics and offers integrated iPSC cell therapy development, GMP manufacturing, CMC, regulatory, and clinical services.
Spotlight
Mon, Oct 5
12:00pm
Innovation Spotlight company presentation
◆Platinum Sponsor
Pharma & large biotechPlatinum Sponsor
Develops and commercializes medicines, including CAR T-cell therapies for cancer and treatments for serious diseases.
Panel
Mon, Oct 5
10:45am
Panel
Tue, Oct 6
8:00am
Why Japan, Why Now: Investment Opportunities and Asia Gateway Strategy
◇Silver Sponsor
Pharma & large biotechSilver Sponsor
Develops and commercializes therapies for cancer, transplant-related disease, and rare genetic disorders.
Panel
Tue, Oct 6
2:15pm
BridgeBio
Palo Alto, CA
◇Silver Sponsor
Pharma & large biotechSilver Sponsor
Develops medicines for genetic conditions through autonomous teams focused on underserved and rare diseases.
Sponsor
In the meeting’s sponsor directory, with no session on the public program
Pharma & large biotech
Develops and commercializes medicines across oncology, CNS, rare diseases, women’s health, urology, and cell and gene therapy.
Spotlight
Tue, Oct 6
3:45pm
Innovation Spotlight company presentation
Panel
Wed, Oct 7
10:00am
iPSCs Come of Age: from Promise to Reality
Eli Lilly
Indianapolis, IN
Pharma & large biotech
Develops and sells prescription medicines across cancer, diabetes, obesity, neuroscience, immunology and other disease areas.
Panel
Tue, Oct 6
9:30am
In vivo Therapies: Current Progress and Future Directions
AstraZeneca
Cambridge, United Kingdom
Pharma & large biotech
Develops and commercializes prescription medicines in oncology, rare diseases, and other biopharmaceutical areas.
Chair
Mon, Oct 5
1:30pm
Convergence vs. Divergence: Global Regulatory Pathways for Advanced Therapies
Gilead Sciences
Foster City, CA
Pharma & large biotech
Develops and commercializes medicines across virology, oncology and inflammation, including cell therapies through Kite.
Panel
Mon, Oct 5
10:45am
Delivering CAR-T: Expanding Access to Transform Patient Care
Sarepta
Cambridge, MA
Pharma & large biotech
Develops and sells genetic medicines, including gene therapies and RNA-based treatments for rare diseases such as Duchenne muscular dystrophy.
United Therapeutics Corporation
Research Triangle Park, NC
Pharma & large biotech
Develops pulmonary medicines and organ-replacement technologies, including gene-edited pig organs, regenerative medicine, bioprinted organs and ex vivo lung perfusion.
Chair
Wed, Oct 7
10:00am
Vor Bio
Boston, MA
Pharma & large biotech
Develops telitacicept, a biologic medicine for autoimmune diseases including lupus, myasthenia gravis and Sjögren’s disease.
Bayer
Leverkusen, Germany
Pharma & large biotech
Develops pharmaceutical medicines, including cell therapies and gene therapies for neurological, ophthalmic and other serious diseases.
Attending
On the meeting’s published attendee list
Bracco
Milan, Italy
Pharma & large biotech
Makes diagnostic imaging pharmaceuticals, contrast agents, molecular imaging tracers, medical devices and related healthcare services.
Attending
On the meeting’s published attendee list
Chiesi USA
Cary, NC
Pharma & large biotech
Develops and commercializes specialty medicines for hospital care, rare diseases, neonatology, critical care and respiratory conditions.
Attending
On the meeting’s published attendee list
CJ America
Los Angeles, CA
Pharma & large biotech
Operates CJ’s American businesses, including biotechnology, food, logistics and entertainment subsidiaries.
Attending
On the meeting’s published attendee list
CJ Cheiljedang
Seoul, South Korea
Pharma & large biotech
Makes food ingredients, pharmaceuticals, and biotechnology products through fermentation and other bio-based manufacturing.
Attending
On the meeting’s published attendee list
Genentech
South San Francisco, CA
Pharma & large biotech
Develops and commercializes prescription medicines for serious diseases, including cancer, neurological, autoimmune and ophthalmic conditions.
Attending
On the meeting’s published attendee list

Explore the full Meeting on the Mesa 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Phoenix. Leave your work email and we’ll be in touch.

Privacy

Download the full Meeting on the Mesa 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find buyers from pharma and large biotech companies

Tell us what you sell and we’ll find the people at these pharma and large biotech companies most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Browse Meeting on the Mesa 2026 by

Not affiliated with or endorsed by the Alliance for Regenerative Medicine or the Cell & Gene Meeting on the Mesa. Submit a correction